Table 2.
Overall characteristics of cancerous samples (n = 72) with and without BLV DNA. The results represent the percentage within each group.
| Tumor Characteristics | Cancerous samples | |
|---|---|---|
| BLV+ (n = 22) | BLV− (n = 50) | |
| Tumoral grade 1 | 0.0% | 14.0% |
| Tumoral grade 2 | 45.5% | 48.0% |
| Tumoral grade 3 | 54.5% | 38.0% |
| Lymph node (+) | 72.7% | 86.0% |
| Lymph node (−) | 27.3% | 14.0% |
| HR+ | 91.0% | 88.0% |
| HR− | 9.0% | 12.0% |
| HER2+ | 13.6% | 12.0% |
| HER2− | 86.4% | 88.0% |
| pT1c + pT2 | 91.0% | 84.0% |
| pT1ab + pT3 | 9.0% | 16.0% |
| Ki67 0–14 | 22.7% | 32.0% |
| Ki67 14–30 | 18.1% | 16.0% |
| Ki67 > 30 | 59.2% | 52.0% |
HR = hormonal receptor; HER2 = human epidermal growth factor receptor 2.